TAT-amide

CAS No. 697226-52-1

TAT-amide ( )

Catalog No. M30407 CAS No. 697226-52-1

TAT-amide is a cell penetrating peptide. Cell-penetrating peptides (CPPs) are short amino acid sequences able to enter different cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote

Biological Information

  • Product Name
    TAT-amide
  • Note
    Research use only, not for human use.
  • Brief Description
    TAT-amide is a cell penetrating peptide. Cell-penetrating peptides (CPPs) are short amino acid sequences able to enter different cells.
  • Description
    TAT-amide is a cell penetrating peptide. Cell-penetrating peptides (CPPs) are short amino acid sequences able to enter different cells.(In Vitro):Cell-penetrating peptides (CPPs) have been employed in cellular delivery of cargoes such as DNA, siRNA, organic halide, ruthenium complex, Zr-labeled antibody for PET imaging, low-molecular-weight chitosan, and fluorescent dyes.
  • Synonyms
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    697226-52-1
  • Formula Weight
    1558.8
  • Molecular Formula
    C64H119N33O13
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Xu P, et al. Precise control of apoptosis via gold nanostars for dose dependent photothermal therapy of melanoma. J Mater Chem B. 2019 Nov 28;7(44):6934-6944.
molnova catalog
related products
  • Pomalidomide-PEG1-CO...

    Pomalidomide-PEG1-CO2H is a synthetic E3 ligase ligand-linker conjugate containing a Pomalidomide-based cereblon ligand and a 2-unit PEG linker.

  • Miglustat

    Miglustat is an alkylated product of imino sugar deoxynojirimycin.It?is an inhibitor of glucosylceramide synthase, primarily to treat Type I Gaucher disease (GD1).

  • CI-976

    CI-976 (PD 128042) is a potent, selective, orally bioavailable inhibitor of ACAT-1 (Acetyl-CoA acetyltransferase 1) with IC50 of 73 nM.